In a memo announcing the news, Amy Coleman, Microsoft's executive vice president and chief people officer, seemingly couched the retirement offer as an alternative to a layoff, following several rounds of cuts that claimed 15,000 jobs over the last year.

The company expects to file for regulatory approval of a label expansion for Ozempic pills in the United States and Rybelsus in the European Union in the second half of this year.

"The reclassification of errors raises the stakes of inspections in an already aggressive enforcement environment," wrote attorneys from employment law firm Littler on the update.